FDA Approval Announced for New Restylane Products Refyne and Defyne

Galderma announced on December 12th, 2016 the FDA approval for Restylane Refyne and Restylane Deflyne dermal fillers. These two new Restylane family products have been approved for the treatment of nasolabial folds (NLF), otherwise known as “laugh lines” for patients over the age of 21. Restylane Defyne was approved for moderate to severe facial wrinkles and […]

FDA Approval Announced for New Restylane Products Refyne and Defyne Read More »